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We report identification of an ankyrin-B-based macromolecular complex of Na/K ATPase (alpha 1 and alpha 2
isoforms), Na/Ca exchanger 1, and InsP3 receptor that is localized in cardiomyocyte T-tubules in discrete microdomains
distinct from classic dihydropyridine receptor/ryanodine receptor ‘‘dyads.’’ E1425G mutation of ankyrin-B, which
causes human cardiac arrhythmia, also blocks binding of ankyrin-B to all three components of the complex. The
ankyrin-B complex is markedly reduced in adult ankyrin-B
þ/  cardiomyocytes, which may explain elevated [Ca
2þ]i
transients in these cells. Thus, loss of the ankyrin-B complex provides a molecular basis for cardiac arrhythmia in
humans and mice. T-tubule-associated ankyrin-B, Na/Ca exchanger, and Na/K ATPase are not present in skeletal
muscle, where ankyrin-B is expressed at 10-fold lower levels than in heart. Ankyrin-B also is not abundantly expressed
in smooth muscle. We propose that the ankyrin-B-based complex is a specialized adaptation of cardiomyocytes with a
role for cytosolic Ca
2þ modulation.
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Introduction
Defects in Ca
2þ homeostasis underlie major diseases of the
heart including congestive heart failure, cardiac hypertrophy,
and fatal cardiac arrhythmias [1,2]. Ca
2þ ions enter cardio-
myocytes through voltage-sensitive Ca
2þ channels (dihydro-
pyridine receptor [DHPR]) located in invaginations of the
plasma membrane known as transverse tubules (T-tubules).
DHPR is localized in a microdomain of the T-tubule that is
synapsed with sites in the sarcoplasmic reticulum (SR) that are
enriched in Ca
2þ-release channels (ryanodine receptor [RyR];
[3,4]). Ca
2þ that enters through DHPR must be balanced in
each contraction cycle (;100 ms in mouse) by Ca
2þ export.
Ca
2þ export is accomplished primarily by the Na/Ca ex-
changer 1 (NCX1), which is driven by the transmembrane Na
þ
gradient provided by the Na/K ATPase (NKA) [5]. The
requirement for rapid export of Ca
2þ is a specialized feature
of heart that is not present in skeletal muscle, where DHPR
directly activates RyR without Ca
2þ import.
Ca
2þ export has historically been an important therapeutic
target in the management of heart failure. Cardiac glycosides
increase [Ca
2þ]i by inhibiting NKA, thus elevating [Na
þ]i and
indirectly inhibiting Ca
2þ efﬂux through NCX1 [6]. Several
considerations suggest that NCX1 and NKA operate together
in diffusion-limited physiological spaces. Cardiac glycosides
do not elevate averaged cytoplasmic [Na
þ] to levels sufﬁcient
to inhibit NCX1, suggesting NKA and NCX are coupled [6,7].
Arrhythmia caused by cardiac glycoside toxicity is believed to
result from a transient inward current carried by NCX1 [8].
However, NCX1 would not be expected to generate inward
ﬂux of Na
þ if averaged [Na
þ] was elevated sufﬁciently to
inhibit Ca
þ2 efﬂux. Numerous studies support a tight func-
tional coupling between NCX1, NKA, and intracellular Ca
2þ
stores in heart [9–13]. However, while co-localization between
NCX1, NKA, and intracellular Ca
2þ stores is described in
smooth muscle [14], the relative localizations of these
proteins in heart are undeﬁned. Additionally, no biochemical
evidence exists for a direct link between NKA, NCX1, and
other SR proteins in cardiomyocytes.
Ankyrin-B is a multivalent adapter present in cardiomyo-
cytes that binds individually to NCX1, NKA, and inositol
1,4,5-trisphosphate receptors (InsP3Rs), and potentially could
play a role in functional coupling of these proteins [15–17].
Loss-of-function mutations in ankyrin-B cause a dominantly
inherited human cardiac arrhythmia syndrome associated
with sudden cardiac death [15,18]. Mice heterozygous for a
null mutation in ankyrin-B (ankyrin-B
þ/  mice) are haploin-
sufﬁcient and have a similar cardiac phenotype as humans
heterozygous for loss-of-function mutations of ankyrin-B
[15,18]. Adult ankyrin-B
þ/  cardiomyocytes exhibit elevated
[Ca
2þ]i transients and, in the presence of beta-catechol-
amines, exhibit delayed and early afterdepolarization events
and extrasystoles [15]. In contrast, action potential duration,
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2þ current, and diastolic [Ca
2þ] are normal in
ankyrin-B
þ/  cardiomyocytes [15].
We report here that NKA (alpha 1 and alpha 2 isoforms),
NCX1, and InsP3R are complexed with ankyrin-B within a
microdomain of cardiomyocyte T-tubules, and that the
complex is deﬁcient in ankyrin-B
þ/  cardiomyocytes. Addi-
tionally, we present evidence that loss of the ankyrin-B-based
complex is the molecular defect in cardiac arrhythmia due to
ankyrin-B mutation in humans and mice. The ankyrin-B
complex is not present in skeletal muscle, smooth muscle, or
brain, and may have evolved in the context of specialized
requirements for cytosolic Ca
2þregulation in cardiomyocytes.
Results
Ankyrin-B Is Required for T-Tubule Localization of NKA,
NCX1, and InsP3R in Cardiomyocytes
Ankyrin-B as well as NKA, NCX1, and InsP3R are selectively
lostfromZ-line/T-tubulesitesinhaploinsufﬁcientankyrin-B
þ/ 
cardiomyocytes [15]. The localization of these proteins was
further resolved by three-dimensional rendering of consec-
utive confocal Z-sections of cardiomyocytes labeled by
immunoﬂuorescence (Figure 1). Wild-type ankyrin-B is or-
ganized in an intracellular tubular lattice in parallel with both
the M-line and Z-line/T-tubules, but also including perpendic-
ular axial branches that connect M-line and Z-line staining
(Figure1C).Z-lineankyrin-Bstainingisco-linearwiththedyad
marker DHPR in two-dimensional images, but is distinct from
the DHPR in three dimensions (,2% of DHPR-positive voxels
[three-dimensional (3D) pixels] overlap with ankyrin-B-pos-
itive voxels; not shown). Z-line ankyrin-B staining signiﬁcantly
overlaps in three dimensions with InsP3R( ;45% of InsP3R-
positive voxels co-localize with ankyrin-B-positive voxels; Fig-
ure1D)aswellasT-tubule-associatedNCX1(;53%;Figure1E)
and NKA (;51%; Figure 1F).
In contrast to wild-type cardiomyocytes, ankyrin-B
þ/  cells
lack Z-line staining as well as the axial lattice of ankyrin-B that
connects Z-line- and M-line-associated populations (Figure
1C–1F, right panels). DHPR staining and organization is
unaffected in ankyrin-B
þ/  cardiomyocytes. InsP3R immuno-
ﬂuorescence (Figure 1D), as well as NCX1 and NKA isoform
staining (Figure 1E and 1F) are markedly reduced at T-tubule
sites. Residual InsP3R, NKA, and NCX1 rarely co-localize with
ankyrin-B (levels of InsP3R, NKA, and NCX1 are reduced to
levels too low for accurate determination of overlap).
Ankyrin-B-Coupled NKA, NCX1, and InsP3R Are Co-
Localized
The Na/Ca exchanger has been localized at sites on cardiac
T-tubules distinct from DHPR and RyR [19]. Moreover, NKA
isoforms, NCX1, and InsP3R have been individually localized
at T-tubule sites in cardiomyocytes [15,19–21]. However,
localizations of all three proteins relative to each other have
not been addressed. The relative localization of NCX1 with
NKA alpha 1 and alpha 2 isoforms, InsP3R, DHPR, and RyR
was evaluated using multiple combinations of double-labeled
3D images of mouse cardiomyocytes generated using confocal
Z-stacks (Figure 2; Table 1). As expected, DHPR and RyR are
co-localized, with ;55% voxel overlap of DHPR with RyR and
;42% overlap of RyR with DHPR (Figure 2B; Table 1), values
comparable to voxel overlaps observed previously [19]. T-
tubule NCX1 immunoﬂuorescence (also localized at the
sarcolemma [21]) is distinct from DHPR staining, with a
Figure 1. NCX1, NKA, and InsP3R Localization Require Ankyrin-B
Boxes in differential interference contrast images (A and B) represent sites that were imaged in (C–F). Immunolocalization of ankyrin-B (red) and (C)
DHPR (green), (D) InsP3R (green), (E) NCX1 (green), and (F) NKA (green) in wild-type (left) and ankyrin-B
þ/  cells (right). Ankyrin-B
þ/  myocytes were
labeled and imaged using identical protocols. M-lines (middle of A-band) are denoted by arrowheads; T-tubules over I-bands are denoted by arrows.
Scale bar¼2 lm. Distance between arrowheads is ;1.8 lm. Images represent at least twenty Z-sections at 0.18-lm intervals. In (C), perpendicular axial
branches are denoted by white arrowheads.
DOI: 10.1371/journal.pbio.0030423.g001
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Ankyrin-B-Based Complex of Channels/Transportersvoxel overlap of less than 5%, as reported previously [19]
(Figure 2C; Table 1).
A new ﬁnding is that T-tubule NCX1 immunoﬂuorescence
co-localizes in submicron-sized domains with the T-tubule
population of both NKA alpha 1 (Figure 2D; Table 1) and
alpha 2 isoforms (Figure 2E; Table 1), with 55% (alpha 1) and
50% (alpha 2) voxel overlap. T-tubule NCX1 also co-localizes
with InsP3R (Figure 2H; Table 1), with 56% of InsP3R voxels
overlapping NCX1 and 50% of NCX1 voxels overlapping
InsP3R. In contrast, InsP3R and RyR are not co-localized at T-
tubule sites, with less than 5% voxel overlap (Figure 2G; Ta-
ble 1). This is the ﬁrst direct evidence to our knowledge that
RyR and InsP3R are localized in spatially deﬁned compart-
ments of the endoplasmic reticulum and SR of ventricular
cardiomyocytes.
NKA alpha 1 and alpha 2 isoforms were similarly
distributed over the T-tubule (Figure 2F; Table 1) and
sarcolemma (not shown). The T-tubule co-localization
occurred in three dimensions as voxels with alpha 1 signal
containing alpha 2 signal ;52% of the time, while voxels
containing alpha 2 signal contained alpha 1 signal ;46% of
the time. NKA isoforms have been proposed to have unique
functions based on differences in localization and/or afﬁnity
for cardiac glycosides [22]. These differences may depend on
the species and cell type, and have not been reported in
mouse cardiomyocytes [23]. Our results in mouse ventricular
cardiomyocytes suggest no major differences in NKA alpha 1
and alpha 2 localization at T-tubules (Figure 2) or sarcolem-
ma (not shown). These results demonstrate co-clustering of
NCX1, NKA, and InsP3R within microdomains along the T-
tubule/SR that are distinct from classic T-tubule/SR junctions
populated by DHPR and RyR. Moreover, the clusters of these
proteins as well as ankyrin-B are reduced or absent in
ankyrin-B
þ/  cardiomyocytes.
T-Tubule-Associated Ankyrin-B Is a Specialized Adaptation
of Cardiomyocytes
The expression of 220-kDa ankyrin-B in skeletal muscle is
nearly 10-fold lower than in heart (Figure 3A). Moreover, in
contrast to ankyrin-B localization in cardiomyocytes (Figure
3B), ankyrin-B is not present over T-tubules of skeletal
muscle, but instead is concentrated at punctate sites on the
sarcolemma, over the A-band, and at costameres (Figure 3B).
Additionally, in contrast to cardiac muscle, NCX1 and NKA
isoforms are nearly undetectable over T-tubules of skeletal
muscle, but are instead concentrated at the sarcolemma
(Figure 3C). Finally, ankyrin-B expression is nearly absent
from smooth muscle (Figure S1), and ankyrin-B-based
complexes of NCX1, NKA isoforms, and InsP3R are not
detectable in brain (see below). Therefore, the ankyrin-B-
based complex of NKA, NCX1, and InsP3R is a specialized
feature of cardiac myocytes.
Ankyrin-B Coordinates NKA, NCX1, and InsP3Ri na
Macromolecular Protein Complex in Cardiomyocytes
The ﬁnding that ankyrin-B is co-localized with NKA, NCX1,
and InsP3R in cardiac T-tubule microdomains and that all of
these proteins are coordinately reduced in ankyrin-B
þ/ 
cardiomyocytes raises the question of their molecular
organization. Given previous evidence that ankyrin-R can
form heterocomplexes between two ankyrin-binding proteins
[24], we wondered whether ankyrin-B could form a multi-
protein complex involving NKA, NCX1, and InsP3Ri n
cardiomyocytes. We therefore performed a series of immu-
noprecipitations from detergent extracts of mouse heart with
antibodies against NCX1, alpha 1 and alpha 2 isoforms of
NKA, and InsP3R, followed by immunoblots to detect
associated proteins (Figure 4). As reported previously,
Figure 2. The Ankyrin-B-Based Complex of NKA, NCX1, and InsP3RI s
Localized in a Specialized T-Tubule Microdomain of Cardiomyocytes
Adult cardiomyocytes were labeled with indicated antibodies. 3D
reconstructions of each cell (A, differential interference contrast) are
shown for each combination. Staining pairs include (B) DHPR (red) and
RyR (green), (C) DHPR (red) and NCX (green), (D) NCX (red) and NKA
alpha1 (green), (E) NCX (red) and NKA alpha 2 (green), (F) NKA alpha 1
(red) and NKA alpha 2 (green), (G) InsP3R (red) and RyR (green), and (H)
InsP3R (red) and NCX (green). Voxel co-localization was performed for
non-sarcolemmal voxels. T-tubule/Z-lines are indicated by white arrows.
Scale bar ¼ 5 lm.
DOI: 10.1371/journal.pbio.0030423.g002
Table 1. Analyses of the Extent of Voxel Co-Localization for
Select Cardiac Protein Pairs
Protein 1
(Alexa 568)
Protein 2
(Alexa 488)
Protein 1
with Protein 2
Protein 2
with Protein 1
n
DHPR RyR2 55.6 6 2.2 41.9 6 4.4 5
DHPR NCX1 3.7 6 2.8 1.8 6 0.9 5
NCX1 NKA alpha 1 54.7 6 3.5 57.8 6 5.4 5
NCX1 NKA alpha 2 50.7 6 2.9 52.8 6 1.9 5
NKA alpha 1 NKA alpha 2 51.8 6 3.8 45.6 6 2.1 5
InsP3RR y R 2 1.7 6 0.9 2.0 6 0.4 5
InsP3R NCX1 56.2 6 5.4 49.6 6 2.6 5
DOI: 10.1371/journal.pbio.0030423.t001
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Ankyrin-B-Based Complex of Channels/Transportersankyrin-B antibody co-immunoprecipitated NKA isoforms,
NCX1, and InsP3R, but not DHPR, SR Ca
2þATPase (SERCA2),
or calsequestrin (Figure 4A) [15]. NCX1 antibody co-
immunoprecipitated 220-kDa ankyrin-B as well as NKA alpha
1 and alpha 2 isoforms and InsP3R; DHPR, SERCA2, and
calsequestrin were not co-immunoprecipitated (Figure 4).
Moreover, NKA alpha 1– and alpha 2–speciﬁc antibodies co-
immunoprecipitated 220-kDa ankyrin-B as well as NCX1 and
InsP3R, but, again, not DHPR, SERCA2, or calsequestrin
(Figure 4A). Finally, antibody speciﬁc for InsP3R also co-
immunoprecipitated 220-kDa ankyrin-B along with NKA
alpha 1 and alpha 2 and NCX1, but not DHPR, SERCA2, or
calsequestrin. DHPR-, SERCA2-, and calsequestrin-speciﬁc
antibodies did not co-immunoprecipitate 220-kDa ankyrin-B,
NCX1, InsP3R, or NKA isoforms. These mutual co-immuno-
precipitations provide evidence for a macromolecular pro-
tein complex in heart containing ankyrin-B coupled to alpha
1 and alpha 2 isoforms of NKA, NCX1, and InsP3R. While
other proteins may be in this protein complex, components
of the classic T-tubule/SR junction (DHPR [also RyR; not
shown]) as well as components of the SR (SERCA2 and
calsequestrin) are not included.
We next asked whether ankyrin-B was required for mutual
co-immunoprecipitation of NKA, NCX1, and InsP3Rb y
comparing wild-type hearts and ankyrin-B
þ/  hearts, which
are deﬁcient in ankyrin-B (Figure 4B and 4C). Ankyrin-B
þ/ 
hearts express reduced levels of 220-kDa ankyrin-B (decreased
;50%), NKA alpha 1 and alpha 2 (both reduced ;15%),
NCX1 (reduced ;16%), and InsP3R (reduced ;33%) [15].
Strikingly, ankyrin-B
þ/  heart lysates exhibited over 60% loss
of the ability of ankyrin-B antibody to co-immunoprecipitate
NKA, InsP3R, or NCX1, even when the quantity of lysate was
doubled to equalize the starting amount of ankyrin-B (Figure
4B). Moreover, a similar reduction in NCX1 co-immunopre-
cipitation of Na/K pump isoforms and InsP3R occurred using
doubled ankyrin-B
þ/  lysates (Figure 4C). NKA alpha 1 and
alpha 2 antibody also failed to co-immunoprecipitate a
signiﬁcant fraction of NCX1 or InsP3R from ankyrin-B
þ/ 
doubled lysates. Finally, InsP3R antibody immunoprecipitated
minimal levels of NCX1 or NKA isoforms from ankyrin-B
þ/ 
heart (Figure 4C). These results demonstrate that a specialized
population of ankyrin-B, which is reduced in ankyrin-B
þ/ 
heart, is critical for ankyrin-B interactions with NKA alpha 1
and alpha 2, NCX1, and InsP3R.
Ankyrin-B, NKA, InsP3R, and NCX1 are all expressed in
brain at levels comparable to those in heart tissue. However,
while immunoprecipitation of 100,000g detergent extracts of
brain tissue with antibody against the InsP3R co-immuno-
precipitated ankyrin-B, NKA and NCX1 were not present
(Figure 4D). Moreover, NKA and NCX1 were also missing
when the immunoprecipitation was performed with antibody
against ankyrin-B (not shown). These results are in contrast to
the report that NCX1, NKA, InsP3R, and ankyrin-B co-
immunoprecipitate along with several other proteins from
27,000g supernatants of detergent extracts from brain [25].
The difference could result from use of a 27,000g supernatant
in the other study and a 100,000g supernatant in our
experimental protocol. A major complication with a lower
speed supernatant is the likely presence of large complexes
such as those connected by short actin ﬁlaments that would
be removed with more centrifugation. Our results demon-
strate that co-expression of ankyrin-B with NCX1 and NKA in
the same tissue is not sufﬁcient for formation of a complex
from a 100,000g supernatant.
Reconstitution of an Ankyrin-B-Based Complex of NKA,
NCX1, and InsP3R
Co-immunoprecipitation experiments as presented in
Figure 4 provide evidence for interactions between ankyrin-
B and its partners in vivo. We next evaluated whether
ankyrin-B could form a complex with the NKA, NCX1, and
InsP3R in vitro using puriﬁed proteins (See Materials and
Methods). We ﬁrst conﬁrmed, using
125I-labeled proteins and
immobilized ankyrin-B membrane-binding domain, that
puriﬁed ankyrin-B membrane-binding domain directly in-
teracts in vitro with puriﬁed NCX1 expressed in Sf9 cells (Kd
¼5 nM), puriﬁed NKA from kidney (Kd¼50 nM), and puriﬁed
InsP3R from cerebellum (Kd ¼ 3 nM) (Figure 5).
Figure 3. The Ankyrin-B-Based Complex Is a Specialized Feature of Heart
(A) Relative expression of 220-kDa ankyrin-B in adult mouse heart and
skeletal muscle (n¼3, p , 0.05). For the immunoblot in the left panel, 50
lg of total lysate was analyzed.
(B) Ankyrin-B (AnkB) immunostaining (red) in frozen sections of heart (H)
and skeletal muscle (Sk Mus, SkM). The Z-lines (arrowheads, also asterisks
in right skeletal muscle panel) overlap with alpha-actinin (green). Arrows
indicate A-bands. Ankyrin-B is localized at costameres in skeletal muscle,
visualized as staining continuous with alpha-actinin near the sarcolem-
ma, but does not extend into the interior. Ankyrin-B localizes over the A-
band in both heart and skeletal muscle. Scale bars ¼ 5 lm.
(C) NCX1 (left panel), NKA alpha 1 (middle panel), and NKA alpha 2
immunostaining (right panel) in skeletal muscle. Scale bars ¼ 18 lm.
DOI: 10.1371/journal.pbio.0030423.g003
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Ankyrin-B-Based Complex of Channels/TransportersWe next asked whether ankyrin-B could form a multivalent
complex with these proteins. Association of InsP3R with NKA
and NCX1 in the presence or absence of soluble ankyrin-B
membrane-binding domain (puriﬁed as a GST-fusion protein
and then cleaved from the GST-tag; Figure 6A) was assessed
using biotinylated InsP3R bound to neutravidin-Dynabeads
(Figure 6B) and
125I-labeled NCX1 and NKA.
125I-labeled
NCX1 and
125I-labeled NKA associated with InsP3R-coated
beads only in the presence of ankyrin-B membrane-binding
domain (Figure 6C). In fact, while the intensity of the NCX1
band is ;50% of the band intensity of NKA (not shown), the
picomoles of each protein bound to the InsP3R-coated beads
was approximately equal (Figure 6C; speciﬁc activity of
125I-
NKA ;504,000 cpm;
125I-NCX1 ;270,000 cpm). In contrast,
125I-labeled NCX1 and
125I-labeled NKA failed to bind to
InsP3R-coated beads in the absence of ankyrin-B (Figure 6C).
Additionally, in the presence of ankyrin-B, InsP3R-coated
beads simultaneously associated with both
125I-labeled NCX1
and
125I-labeled NKA with no decrease in binding capacity
compared to reactions where only one labeled protein was
used (Figure 6C). These results demonstrate that interaction
of InsP3R with either NCX1 or NKA is ankyrin-B-dependent
and that these proteins can assemble in vitro in the absence
of additional co-factors or regulatory proteins.
Human E1425G Mutation Abolishes Ankyrin-B Association
with NCX1, NKA, and InsP3R
One test of the physiological importance of the ankyrin-B-
based complex is whether mutations in ankyrin-B resulting in
loss of the complex also cause arrhythmia. E1425G mutation
Figure 4. Ankyrin-B Forms a Macromolecular Complex with NKA, NCX1, and InsP3R That Is Missing in Ankyrin-B
þ/  Heart
(A) Immunoprecipitations and co-immunoprecipitations from detergent-soluble extracts from adult mouse heart.
(B and C) Detergent-soluble lysates from wild-type or ankyrin-B
þ/  mouse hearts were used for immunoprecipitations with indicated antibodies (IB,
immunoblot; IP, immunoprecipitation). Immunoprecipitations of ankyrin-B
þ/  extracts employed doubled amounts of input lysate to compensate for
50% reduction of ankyrin-B.
(D) InsP3R co-immunoprecipitates 220-kDa ankyrin-B, NCX1, and NKA from detergent-soluble heart lysates (Input ¼ 10%). In contrast, InsP3R co-
immunoprecipitates 220-kDa ankyrin-B, but not NCX1 or NKA, from detergent-soluble lysates of mouse brain (Input ¼ 10%).
ANKB, ankyrin-B; C. IG, control Ig.
DOI: 10.1371/journal.pbio.0030423.g004
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Ankyrin-B-Based Complex of Channels/Transportersof ankyrin-B causes human cardiac arrhythmia and loss of
activity of ankyrin-B in restoring normal Ca
2þ waves to
ankyrin-B
þ/  neonatal cardiomyocytes [15]. The mechanism
for loss of function due to the E1425G mutation, which is
located close to the C-terminal regulatory domain and distant
from the membrane-binding domain (Figure 7A), is not
known. However, the regulatory domains of ankyrins (Figure
7A) can modulate activities of N-terminal membrane- and
spectrin-binding domains [26,27].
The effect of the E1425G mutation on the ability of ankyrin-
B to bind to NKA, NCX1, and InsP3R was evaluated using
detergent extracts of heart tissue (not shown) and using
puriﬁed proteins isolated as in Figure 6A. Evaluation of the
binding properties of the E1425G mutant protein requires
full-length 220-kDa ankyrin-B. We have not yet successfully
generated full-length 220-kDa ankyrin-B in bacteria. There-
fore, we used mammalian HEK293 cells to generate full-length
wild-type and mutant ankyrin-B polypeptides for our binding
studies. Recombinant green ﬂuorescent protein (GFP)–220-
kDa ankyrin-B that was either wild-type, with the E1425G
mutation, or with a E1425D mutation was expressed and
immuno-isolated from HEK293 cells using an afﬁnity-puriﬁed
antibody against GFP immobilized on Protein A agarose.
The levels of immobilized GFP-ankyrins were all equivalent
in these assays (Figure 7B). E1425G ankyrin-B exhibited a
60%–70% loss of association with NCX1, NKA alpha 1 and
alpha 2, and InsP3R from cardiac lysates (not shown), and as
pure proteins (Figure 7C–7E). The conservative E1425D
mutation at this site had no effect on binding of NCX1,
NKA, or InsP3R (Figure 7C–7E). The ﬁnding that the E1425G
mutation abolishes the ability of ankyrin-B to bind to NCX1,
NKA, and InsP3R (Figure 7) suggests that interaction of
ankyrin-B with either all three or some combination of these
proteins is required for its function. It is possible that the
E1425G mutation affects other protein interactions of
ankyrin-B, although these remain to be identiﬁed.
Discussion
This study presents the discovery of an ankyrin-B-based
macromolecular complex of NKA (alpha 1 and alpha 2
isoforms), NCX1, and InsP3R in cardiomyocytes. The complex
is localized in a microdomain along cardiomyocyte T-tubules
resolved by 3D confocal microscopy as distinct from the
classic dyad formed by DHPR and RyR. This microdomain
was ﬁrst described by Moore and colleagues, who also
distinguished the T-tubule NCX1 from dyad proteins RyR
and DHPR and from voltage-gated sodium channels by light
microscopy using image deconvolution and wide-ﬁeld epi-
ﬂuorescence microscopy [19]. T-tubule-associated ankyrin-B
is a specialized adaptation of cardiomyocytes and is not
evident in smooth muscle, which does not express signiﬁcant
ankyrin-B levels, or in skeletal muscle, where ankyrin-B is
expressed at 10-fold lower levels than in heart. The T-tubule
domain containing ankyrin-B-coupled NKA, NCX1, and
InsP3R thus is a specialized adaptation of cardiac cells that
is not present in other types of muscle cells.
We propose a scale model for the ankyrin-B-based complex
(Figure 8) based on previous structural reports and on
evidence from this study that ankyrin-B can promote
association between puriﬁed NKA, NCX1 and InsP3R (see
Figure 6). In this scheme, the extended ankyrin-B membrane-
binding domain adapts the NKA and NCX1 to the InsP3Ri na
conﬁguration that would allow for regulation of cytosolic
Ca
2þ in a spatially privileged domain (Figure 8). It is likely
that all participants in such an assembly have mutually
interacting surfaces. In this case, the role of ankyrin-B could
be to stabilize the assembly and/or possibly direct its cellular
localization. The resulting macromolecular complex capable
of coupled transport would accomplish the intended purpose
of ‘‘restricted space’’ previously invoked to explain the action
of cardiac glycosides [28]. However, the dimensions of a
complex would be on the order of 10–20 nm, while an
anatomical space or ‘‘synapse’’ between the endoplasmic
reticulum and plasma membrane is 500–1,000 nm in size and
would not provide a effective barrier to diffusion of small
ions with radii less than 1 nm. A test of the idea of coupled
transport by ankyrin-B-complexed proteins would be to
selectively interfere with participation of individual members
of the complex by knocking in mutants lacking ankyrin-B-
binding activity.
Figure 5. Purified NCX1, NKA, and InsP3R Directly Interact with Purified Ankyrin-B Membrane-Binding Domain
Saturation binding of purified (A)
125I-labeled NCX1, (B)
125I-labeled NKA (NKA), and (C)
125I-labeled InsP3R with glutathione Sepharose–immobilized
GST-ankyrin-B membrane-binding domain or GST control Sepharose. Inset for each panel represents Scatchard analysis of ankyrin-B interactions
following subtraction of nonspecific binding to GST-Sepharose. Proteins were isolated as described in Materials and Methods.
DOI: 10.1371/journal.pbio.0030423.g005
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Ankyrin-B-Based Complex of Channels/TransportersWhile binding and localization data are consistent with
simultaneous interaction of a single ankyrin-B molecule with
NCX1, NKA, and InsP3 receptor, it also is possible that only
one or two ankyrin-B-associated proteins are bound at a
given time. It will be important in future experiments to
isolate ankyrin-B-based macromolecular assemblies and
directly determine stoichiometries of component proteins.
A current challenge is that ankyrins also associate with
spectrin and spectrin/actin complexes (reviewed in [17]), as
well as proteins such as obscurin [29,30].
A role for InsP3R in heart is unknown. InsP3R-dependent
Ca
2þ signaling has been proposed to regulate excitation–
contraction coupling in atrial myocytes by modulation of the
activity (priming) of juxtaposed RyR [31]. However, based on
the low ratio of InsP3R to RyR [32], the high Ca
2þ buffering
capacity of the cytosol [33], and now the distinct localizations
of these Ca
2þ-release channels, it is unlikely that InsP3RC a
2þ
release could affect the activity of RyR-mediated Ca
2þ-
induced Ca
2þ release in ventricular cardiomyocytes. Also, a
role of InsP3Ri nC a
2þ signaling is difﬁcult to reconcile with
an environment where [Ca
2þ]i transients occur continuously
[2]. Our model suggests a counterintuitive role for InsP3Ra sa
‘‘Ca
2þ pressure valve’’ for export of excess SR Ca
2þ from the
cell (Figure 8). Consistent with this idea is experimental
evidence for functional coupling of SR Ca
2þ stores with Ca
2þ
efﬂux [9,11].
Loss of the ankyrin-B-based complex may provide an
explanation for the cardiac arrhythmia syndrome due to
ankyrin-B mutations in humans and mice. The E1425G
mutation of ankyrin-B, which causes human cardiac arrhyth-
mia, also blocks binding of ankyrin-B to all three components
(NCX1, NKA, and InsP3R) of the complex (see Figure 7).
Moreover, ankyrin-B
þ/  mice have a related cardiac arrhyth-
mia, and ankyrin-B
þ/ cardiomyocytes are also deﬁcient in the
complex, while the expression and subcellular localization of
other cardiac ion channels and transporters (e.g., Nav
channels, which associate with a second ankyrin gene
Figure 6. Reconstitution of the NCX1, NKA, and InsP3R Complex Requires
Ankyrin-B
(A) Purified NKA (a/b subunits), InsP3R, NCX1, and ankyrin-B membrane-
binding domain (ANKB MBD) were examined by SDS-PAGE and
Coomassie blue.
(B) Stained gel of control beads and beads plus purified InsP3R.
(C) NKA and NCX1 were
125I-labeled and incubated with control
Dynabeads or Dynabeads coated with InsP3R with or without ankyrin-B
membrane-binding domain. Bound protein was analyzed by a gamma-
counter (C) and by SDS-PAGE and phosphorimaging (not shown; see
Materials and Methods for protein measurement, n ¼ 3, p , 0.05).
DOI: 10.1371/journal.pbio.0030423.g006
Figure 7. Human Ankyrin-B E1425G Mutation Abolishes Binding to NKA,
NCX1, and InsP3R
(A) 220-kDa ankyrin-B domain organization. The human LQT4 E1425G
mutation is marked.
(B) Immunoblot of expressed wild-type and mutant GFP-ankyrin-B
proteins.
(C–E) Relative binding of rat heart lysate (C) InsP3R, (D) NCX1, and (E) NKA
to wild-type and mutant GFP-ankyrin-B proteins. Bound NCX1, NKA, and
InsP3R were evaluated following quantitative immunoblot (pan-InsP3R,
pan-NKA, and NCX1 Ig) and phosphorimaging (n ¼ 3, p , 0.05).
DOI: 10.1371/journal.pbio.0030423.g007
PLoS Biology | www.plosbiology.org December 2005 | Volume 3 | Issue 12 | e423 2164
Ankyrin-B-Based Complex of Channels/Transportersproduct, ankyrin-G) remain normal [15,18,34]. The electrical
basis for ankyrin-B-dependent cardiac arrhythmia has been
proposed, based on observations with ankyrin-B
þ/  cardio-
myocytes, to be due to elevated Ca
2þ transients that provoke
afterdepolarizations and extrasystoles following catechol-
amine-induced stress [15]. These predictions of a calcium-
based phenotype are also supported by absence of abnormal-
ities in the localization or expression of Nav channels (also
normal cardiac action potentials) and K channels in ankyrin-
B
þ/  and ankyrin-B
 /  cardiomyocytes [15,18]. Absence of the
ankyrin-B complex would be predicted to result in less
efﬁcient export of calcium from the SR and could result in
elevated calcium transients.
Ankyrin-B
þ/  cardiomyocytes display preferential loss of
ankyrin-B immunoreactivity at Z-line/T-tubule domains
compared with M-line staining (see Figure 1). Potential
explanations for this preferential loss may include reduced
T-tubule ankyrin-B protein stability (half-life), increased T-
tubule/SR membrane turnover, or differences in the associ-
ation of each ankyrin-B population with the underlying
cytoskeleton. Alternatively, reduced expression of the T-
tubule/SR population of ankyrin-B in ankyrin-B
þ/  cardio-
myocytes may result from differences in the molecular
identities of ankyrin-B polypeptides at each domain. For
example, ankyrin-B immunoreactivity at the M-line may
represent an ankyrin-B splice form that lacks Ank2 exon 23
(exon targeted in the ankyrin-B knock-out mouse) but still
reacts with ankyrin-B Ig.
Interaction between InsP3R and ouabain-associated Na/K
pump has been reported to be responsible for slow Ca
2þ
oscillations in cultured renal proximal tubule and Cos7 cells
[35]. Our results with pure proteins suggest that InsP3R and
the NKA do not interact directly, at least not with high
afﬁnity (see Figure 7). Thus, it will be of interest to evaluate
possible participation of ankyrin-B or possibly other adaptor
proteins in this system. More generally, determinants of
cellular localization and partnerships with physiologically
related proteins likely are an essential aspect of function for
all ion channels and transporters. Ankyrins are ubiquitously
expressed and display diversity in protein interactions. Based
on the ﬁndings of this study, and previous ﬁndings that
ankyrin-G is required for coordinating voltage-gated Na
channels and L1CAM cell adhesion molecules at axon initial
segments [36,37], we predict that ankyrins are likely to
contribute to higher order organization of multiple channels
and transporters in a variety of tissues.
Materials and Methods
Animals. Mice used in these studies were adult WT C57BL/6 mice
and ankyrin-B
þ/  littermates (C57BL/6), 3–6 mo of age and weighing
30–40 g. Animals were handled according to approved protocols and
animal welfare regulations of the Institutional Review Board of Duke
University Medical Center. Mouse ventricular cardiomyocytes were
isolated as described in [15].
Immunoﬂuorescence. Antibodies not described in [15] include
NCX1 (Afﬁnity Bioreagents, Golden, Colorado, United States; Swant,
Bellinzona, Switzerland), alpha 1 and alpha 2 ATPase (Transduction),
DHPR (ABR, Alomone), afﬁnity-puriﬁed GFP polyclonal Ig, and
afﬁnity-puriﬁed pan-InsP3R polyclonal Ig generated against the C-
terminus of mouse InsP3R (residues 2592  2750). When unavoidable,
mouse cells were immunostained with monoclonal antibodies that
had been ﬁrst afﬁnity-puriﬁed. For these monoclonal antibodies, we
conﬁrmed that our staining was speciﬁc by control experiments in rat
cells. Additionally, Alexa anti-mouse secondary antibodies were
examined for background immunoreactivity. Adult cardiomyocytes
were stained as described [15]. Isolated ventricular mouse cardio-
myocytes were double-labeled and imaged in three dimensions by
rendering of confocal Z-scans obtained at 0.18-lm increments near
the center of isolated cells using a 100 power/1.45 NA objective (LSM
510, Zeiss, Oberkochen, Germany). LSM Z-stacks were transferred to
Volocity software (Improvision, Lexington, Massachusetts, United
States), and identical protocols were used for 3D rendering of WT
and ankyrin-B
þ/  cells. Volocity Classiﬁcation software or LSM 510
software was used to measure voxel or pixel co-localization. Data
represent at least three separate experiments with at least ﬁve areas
measured for each experiment. Areas measured do not include
sarcolemmal membrane voxels. Using monoclonal and polyclonal
antibody directed against the same protein, cardiac double-labeling,
and voxel co-localization revealed that the maximal co-localization
for the same protein was ;65% consistent with previous studies [19].
Ankyrin-B mutagenesis. GFP–220-kDa ankyrin-B mutants E1425G
and E1425D were created using site-directed mutagenesis. The
mutated region was subcloned into a native GFP–220-kDa ankyrin-
B plasmid, and the plasmid was completely sequenced to verify that
no additional mutations were introduced.
Statistics. When appropriate, data were analyzed using a two-tailed
Student’s t-test, and values less than p , 0.05 were considered
signiﬁcant. Values are expressed as the mean 6 standard deviation.
Protein modeling. 3D protein structures for the model in Figure 8
were approximated based on published structures [38–43].
Immunoprecipitation and solubilization of heart proteins. Adult
heart immunoprecipitations and quantitative immunoblotting were
performedas described [15]. Brieﬂy,adult mouseheart and brain were
dissected and rinsed in PBS plus 0.32 M sucrose and 2 mM Na EDTA,
ﬂash frozen in liquid nitrogen, and ground into a ﬁne powder. The
powder was resuspended in 4 volumes of 50 mM Tris HCl (pH 7.35), 10
mM NaCl, 0.32 M sucrose, 5 mM Na EDTA, 2.5 mM Na EGTA, 1 mM
Figure 8. Model of the Cardiac Ankyrin-B Complex
(Left) Model of ankyrin-B-dependent complex of NKA, NCX1, and InsP3R at T-tubule/SR sites distinct from the classic ‘‘dyad.’’
(Right) Scale model of ankyrin-B complex based on approximate dimensions of represented proteins. The protein ratios are not representative for in
vivo couplings as there are likely 50–100 RyR2 for each InsP3R in a ventricular cardiomyocyte [32].
DOI: 10.1371/journal.pbio.0030423.g008
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Ankyrin-B-Based Complex of Channels/TransportersPMSF, 1 mM 4-(2-aminoethyl) benzenesulfonylﬂuoride hydrochloride
(AEBSF), 10 lg/ml leupeptin, and 10 lg/ml pepstatin using a Dounce
homogenizer (Kimble/Kontes, Vineland, New Jersey, United States).
Thehomogenatewascentrifugedat 1,000gto removenuclei.TritonX-
100 and deoxycholate were added to the post-nuclear supernatant for
ﬁnal concentrations of 1.5% Triton X-100 and 0.75% deoxycholate.
The lysate was pelleted at 100,000g for 1 h at 4 8C, and the supernatant
was re-cleared at 100,000g for 1 h to remove residual large membranes
or vesicles. The resulting supernatant was used for immunoprecipi-
tation (see Figure 4) as described [16], or for binding experiments.
Binding studies. GFP–220-kDaankyrin-Bandmutants(E1425Gand
E1425D) were expressed in HEK293 cells and puriﬁed using afﬁnity-
puriﬁed GFP Ig coupled to Protein A agarose beads. Brieﬂy, cells were
lysedinabovehomogenizationbufferplus1.0%TritonX-100and0.5%
deoxycholate. The extract was centrifuged at 100,000g, and the
supernatant was incubated with GFP afﬁnity-puriﬁed Ig coupled to
Protein A sepharose. The beads were washed with homogenization
buffer plus 1.0% Triton X-100. Puriﬁed proteins were incubated with
10 lg of afﬁnity-puriﬁed GFP Ig or control Ig coupled to Protein A
sepharose beads for 4 h at 4 8C. The beads were washed four times with
homogenizationbufferplus1.0%TritonX-100.Proteinboundtoeach
mutant GFP–220-kDa ankyrin-B was eluted, analyzed by quantitative
125I-labeled Protein A immunoblot, normalized for relative GFP–
ankyrin-B expression, and then compared to WT GFP–220-kDa
ankyrin-B binding.
For in vitro complex reconstitution experiments, 0.5 ml of
Dynabeads M-270 Epoxy (1310
9) beads (Dynal Biotech, Brown Deer,
Wisconsin, United States) were washed in PBS and incubated with 5
mg of neutravidin in PBS in a ﬁnal volume of 1 ml for 48 h at 25 8C.
Beadswerethen washedin BSAbindingbuffer (20mMHepes [pH7.3],
50 mM NaCl, 1 mM Na EDTA, 0.1% Triton X-100, 1 mM sodium azide,
and 5 mg/ml BSA). Puriﬁed InsP3R (0.5 ml; 200 lg/ml) was incubated
with a 20-fold molar excess of NHS-LC-biotin (Pierce Biotechnology,
Rockford, Illinois, United States) overnight at 4 8C. For control biotin,
the same biotin was incubated overnight in PBS. Biotin-InsP3R was
then dialyzed against binding buffer without BSA to remove unbound
biotin. Then 50% of the neutravidin Dynabeads were pre-incubated
withthecontrolbiotinfor 2h at 4 8C, washed,and resuspendedin BSA
binding buffer (control neutravidin Dynabeads). Neutravidin Dyna-
beads were incubated with the dialyzed biotin-InsP3R while control
neutravidin Dynabeads were incubated with the same concentration
of unlabeled InsP3R for 2 h at 4 8C. Dynabeads were then washed 33in
BSA binding buffer and used for binding experiments. Coated
Dynabeads (InsP3R at 20 nM) were incubated with
125I-labeled NCX1
(20 nM ﬁnal concentration; speciﬁc activity 274,000 cpm/pmol) and/or
125I-labeled NKA (20 nM ﬁnal concentration; speciﬁc activity
;504,000 cpm/pmol) in the presence or absence of a pre-incubation
with ankyrin-B membrane-binding domain (20 nM ﬁnal concentra-
tion) in a ﬁnal volume of 50 ll of BSA binding buffer (20 mM Hepes
[pH 7.3]; 50 mM NaCl, 1 mM Na EDTA, 0.2% Triton X-100, 1 mM
NaN3, and 5 mg/ml BSA). Following 4 h, the beads were washed in
binding buffer minus BSA, and both pellet and supernatant samples
were assayed for
125I in a gamma counter (n ¼ 3). The samples were
then examined by SDS-PAGE and phosphorimaging (n¼3). Values for
picomoles bound of
125I-labeled NCX1 or
125I-labeled NKA in
experiments where only one labeled ligand was used were calculated
from counts of
125I-labeled protein bound and speciﬁc activity.
Values for picomoles bound of
125I-labeled NCX1 and
125I-labeled
NKA when two labeled proteins were incubated together (
125I-
labeled NCX1 þ
125I-labeled NKA) were calculated by ﬁrst determin-
ing a ratio of counts of
125I-labeled protein bound/band intensity for
unique bands of
125I-labeled NCX or
125I-labeled NKA in single
protein binding experiments (i.e.,
125I-labeled NCX þ ankyrin-B þ
InsP3R beads). The intensity of these same bands was measured in the
gel lanes where the two proteins (i.e.,
125I-labeled NCX þ
125I-labeled
NKA þ ankyrin-B þ InsP3R beads) were combined to determine the
number of picomoles bound of each protein. We observed
approximately equal picomoles of
125I-labeled NCX1 and
125I-labeled
NKA bound to InsP3R beads when ankyrin-B was included in the
binding reaction. However, because of the lower speciﬁc activity of
125I-labeled NCX1, the band intensity on the gel was approximately
50% of that of
125I-labeled NKA. Saturation binding was performed
essentially as described in [16] but using glutathione beads. Brieﬂy,
ankyrin-B membrane-binding domain was puriﬁed as described in
[16]. Increasing concentrations of
125I-labeled InsP3R,
125I-labeled
NCX1, or
125I-labeled NKA were incubated for 2 h at 25 8C with
glutathione Sepharose-immobilized GST-ankyrin-B membrane-bind-
ing domain or GST. The beads were washed and counted in a gamma
counter. The data were corrected for nonspeciﬁc binding at each
concentration by subtracting values obtained with GST-coated beads.
Protein puriﬁcation. Full-length human NCX1 was cloned from a
human heart library (Clontech, Palo Alto, California, United States)
into pBacPak9 (Clontech) using standard molecular techniques. For
puriﬁcation of NCX1, a His-tag was engineered to the C-terminus.
NCX1 was expressed in SF21 insect cells using a generated
recombinant baculovirus. Cells were infected in monolayer cultures
with a MOI of ten for 72 h at 27 8C. Cells were harvested and washed
in PBS, and cell pellets were snap frozen and stored at  80 8C. All
subsequent procedures were performed at 4 8C in the presence of
protease inhibitors (100 lg/ml AEBSF, 100 lg/ml benzamidine, 30 lg/
ml leupeptin, and 10 lg/ml pepstatin). Cells were syringed and
sonicated in cell homogenization buffer (PBS, 1 mM Na EDTA, 1 mM
DTT, and 1 mM sodium azide) to break the cell membranes, then
centrifuged at 100,000g for 30 min to collect membranes. Cell
membranes were pre-extracted with 20 mM CHAPS (pH 12) for 30
min followed by 20 mM PB (pH 7.3), 0.5 M NaCl, 0.5 M urea, 0.5%
Triton X-100, and 0.5 mM beta mercaptoethanol. The cell residue was
resuspended in extraction buffer (50 mM PB (pH 8.0), 0.3 M NaCl, 10
mM imidazole, 0.2% Triton X-100, 1 mM beta mercaptoethanol, 1
mM sodium azide, and 2% Sarkosyl) for 20 min. The extract was
centrifuged at 100,000g for 1 h, and the supernatant collected and
diluted 10-fold in buffer lacking Sarkosyl. The diluted extract was
applied to a column of Ni-NTA Sepharose, washed with 10–20
column volumes of dilution buffer, and eluted with buffer plus 0.3 M
imidazole. Peak fractions were pooled, adjusted to 10% glycerol, snap
frozen, and stored at  80 8C. Sheep kidney NKA was isolated in
membrane-bound form from outer medulla as previously described
[44]. The NKA was extracted and puriﬁed as previously described
[45]. The InsP3R was puriﬁed from frozen bovine brain cerebellum by
a modiﬁcation of published procedures [16,46]. All procedures were
carried out at 4 8C in the presence of protease inhibitors (100 lg/ml
AEBSF, 100 lg/ml benzamidine, 30 lg/ml leupeptin, and 10 lg/ml
pepstatin). Cerebellum was homogenized using a polytron in ﬁve
volumes (weight/volume) of homogenization buffer (10 mM Hepes
[pH 7.3], 0.32 M sucrose, 2 mM EGTA, 1 mm DTT, and 1 mM sodium
azide), and centrifuged at 2,000 rpm for 10 min. Membranes were
then collected at 30,000g for 1 h. Membranes were prewashed in wash
buffer (50 mM Tris HCl [pH 8.0], 1 mM Na EGTA, 1 mM DTT, and 1
mM Na azide), then resuspended to the homogenization volume with
the wash buffer. InsP3R was extracted from the membranes by the
addition of 2% ﬁnal Triton X-100 for 30 min, and supernatants
collected after centrifugation at 30,000g for 1 h. The extract was
adjusted to 0.25 M NaCl and applied to a 50-ml heparin Sepharose
column equilibrated in 0.25 M NaCl and 0.2% Triton X-100
extraction buffer. The heparin Sepharose was washed with ten
column volumes of equilibration buffer, and then eluted with 0.5 M
NaCl buffer. Peak fractions were pooled and dialyzed against ten
volumes of column buffer lacking NaCl and 20 mM Tris HCl (pH 8.0).
A precipitate formed after dialysis and was collected by centrifuga-
tion at 100,000g for 20 min. The pellet was resuspended in column
buffer with the addition of 1.0 M NaCl and was re-centrifuged as
above. The InsP3R released into the supernatant was then adjusted to
0.2 mM CaCl2 and 0.2 mM MnCl2, and applied to a 4-ml ConA
Sepharose column. The column was washed in 20 column volumes of
buffer, the elution started with the addition of 1 M mannose, the
elution stopped, and the column allowed to sit in elution buffer
overnight. The elution was continued the following day and fractions
collected, aliquoted, snap frozen, and stored at  80 8C.
Supporting Information
Figure S1. Ankyrin-B-Based Complex Is a Specialized Feature of
Cardiac Myocytes
Ankyrin-B is expressed in ventricular cardiomyocytes but not in
smooth muscle lining large arteries. Image represents adult mouse
heart immunostained with ankyrin-B-speciﬁc Ig.
Found at DOI: 10.1371/journal.pbio.0030423.sg001 (2.7 MB TIF).
Accession Number
The NCBI (http://www.ncbi.nlm.nih.gov/) accession number for
ankyrin-B is NM_020977.
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